Number V Oral lichen planu- s: clinical features and management. Oral Dis 2005; 11: 338-349.Eisen D, Carrozzo M, Bagan Sebastian JV, et al. Number V oral lichen planus: clinical features and management. Oral Dis. 2005;11:338-349....
Eisen D. The clinical features, malignant potential, and systemic associations of oral lichen planus: a study of 723 patients. J Am Acad Dermatol. 2002;46(2):207–14. ArticlePubMedGoogle Scholar Xue JL, Fan MW, Wang SZ, Chen XM, Li Y, Wang L. A clinical study of 674 patients with ...
Objectives: To describe the clinical features of patients diagnosed with oral lichen planus (OLP) and to establish the prevalence of its malignant transformation in our setting. Study design: A retrospective study was made of 65 patients clinically and histologically diagnosed with OLP in the Service...
Lichen planus is a cell-mediated immune response of unknown origin. It may be found with other diseases of altered immunity, such as ulcerative colitis, alopecia areata, vitiligo, dermatomyositis, morphea, lichen sclerosis, and myasthenia gravis.
"Mucosal vulval lichen planus: outcome, clinical and laboratory features.[Erratum appears in J Eur Acad Dermatol Venereol. 2005 Jul;19(4):530]." Journal of the European Academy of Dermatology & Venereology 19(3): 301-307.Kirtschig G, Wakelin SH, Wojnarowska F (2005b) Mucosal vulval ...
Oral lichen planus (OLP) is a T cell-mediated inflammatory autoimmune disease. Autophagy has emerged as a fundamental trafficking event in mediating T cell response, which plays crucial roles in innate and adaptive immunity. The present study mainly investigated the mRNA expression of autophagy-associ...
Clinical features Lichen planus is categorized based on the areas of involvement: cutaneous, mucosal, and appendageal. The most common cutaneous and mucosal manifestations are presented here. Additional manifestations are described in “Subtypes and variants.” [1] Cutaneous lichen planus [2][7] 6...
Clinical and epidemiological data from 232 patients with lichen planus is presented. Lichen planus constituted 0.38% of the total dermatology, outpatients diagnosed. The patient ages ranged from 8 to 76 years, most being in the age range from 20 to 49 years. Duration of disease varied from 1 ...
Lichen planus is a cell-mediated immune response of unknown origin. It may be found with other diseases of altered immunity, such as ulcerative colitis, alopecia areata, vitiligo, dermatomyositis, morphea, lichen sclerosis, and myasthenia gravis.
Lichen planus is an inflammatory mucocutaneous disease that can present with a variety of clinical manifestations. Pathogenetic mechanisms of LP still remain unknown; however, most of the present evidence supports that epithelial damage results from T-cell–mediated keratinocyte apoptosis triggered by a ...